Status:
COMPLETED
ToleroMune Ragweed Follow up Study
Lead Sponsor:
Circassia Limited
Collaborating Sponsors:
Adiga Life Sciences, Inc.
Cetero Research, San Antonio
Conditions:
Ragweed Allergy
Rhinoconjunctivitis
Eligibility:
All Genders
18-65 years
Brief Summary
Ragweed is the primary cause of autumn allergies. The ragweed season begins in mid-August. In the third National Health and Nutrition Examination Surveys54.3% of the population had positive test respo...
Detailed Description
Subjects who were randomised in study TR002 and who completed all dosing visits and the PTC will be invited to attend the Screening Visit for TR002B. Subjects will attend the EEC for 4 visits on succe...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Previously randomised into study TR002 and completed all treatment visits and the PTC.
- Exclusion Criteria
- History of asthma (a diagnosis of asthma in childhood may be allowed).
- Subjects with an FEV1 \<70% of predicted.
- Subjects being treated with beta-blockers.
- Developed a significant disease, disorder or inability to communicate, since completing study TR002 which, in the opinion of the Sponsor's medical representative, may either put the subject at risk because of participation in the study, or influence the results of the study, or the subject's ability to participate in the study.
Exclusion
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT01448603
Start Date
October 1 2011
End Date
March 1 2012
Last Update
May 17 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cetero Research
Mississauga, Ontario, Canada, L4W 1N2